Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04781712
Other study ID # SMC-2018-10-062
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 22, 2019
Est. completion date March 30, 2021

Study information

Verified date October 2022
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigated the feasibility of the novel modular mobile health (mHealth) for personalized rehabilitation and explored the participants' satisfaction and app data during treatment of breast cancer.


Description:

This is prospective, feasible, parallel study in post-operative patients with breast cancer and during treatment. Disability of Arm, Shoulder, Hands (DASH), Physical activity data (IPAQ-SF), Physical measurement such as hand grip strength, body mass index (BMI), muscle mass, and differences in arm circumference, PRO-CTCAE, Distress Thermometer, needs and satisfaction in app, personal health record of app (exercise, daily step count, etc.) Measure will be evaluated on 1-month, 2-month, 4-month, 6-month, 9-month, and 12-month after POD.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date March 30, 2021
Est. primary completion date March 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria: - Unilateral breast cancer at TNM stage 0 ~ III - Patients who will undergo the treatment (chemotherapy, radiation therapy, and hormone therapy) after surgery - Patients who had a mobile phone (Android or iOS) Exclusion Criteria: - Patients who have metastases or recurrence to other organs were excluded

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Modular mHealth for Tailored Rehabilitation
an individually tailored self-management through the mHealth app with a smart band worn on the wrist

Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul Gangnam-gu

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary satisfaction score in app contents satisfaction score in app contents, Likert scale (5-point, higher scores mean a better) 1 to 12month
Primary Needs score in app contents Needs score in app contents, Likert scale (5-point, higher scores mean a better) 1 to 12month
Primary DASH (Disabilities of Arm, Shoulder, Hands) Change from Baseline DASH score at 12 months, higher scores mean a worse (0-100) 1 month, 2month, 4month, 6month, 9month, 12month
Secondary Physical measurement (handgrip strength) Handgrip strength (kg) 1 to 12month
Secondary Physical measurement (of body composition, BMI) Body mass index 1 to 12month
Secondary Physical measurement (of body composition, muscle mass) muscle mass 1 to 12month
Secondary Physical measurement (upper extremity volume) differences in arm circumference 1 to 12month
Secondary Physical activity (IPAQ-SF Questionnaire) Total METs within recent 7 days (vigorous, moderate, walking, sitting), higher values mean a better 1 to 12month
Secondary PRO-CTCAE (patients reported outcomes) Symptoms during treatment 1 to 12month
Secondary Distress thermometer (distress level) Distress level during treatment, higher scores mean a worse (0-10) 1 to 12month
Secondary App use data (personal health record)_Exercise compliance rate Exercise time, higher values mean a better 1 to 12month
Secondary App use data (personal health record)_Physical activity change daily step count (number), higher values mean a better physical activity 1 to 12month
Secondary App use data (personal health record)_interest of contents contents view (number), higher values mean a better compliance rate 1 to 12month
Secondary App use data (personal health record)_sleep sleep compliance rate (%), higher values mean a better compliance rate 1 to 12month
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A